Camber’s Amlodipine has a Big Impact on the Market
As reported in the Wall Street Journal and the New York Times, Camber Pharma’s Amlodipine, the generic for blood-pressure drug Norvasc has made an immediate and substantial impact on the generics marketplace quickly building a 9 percent share of the overall sales. To view the complete article click the link below.
http://blogs.wsj.com/health/2010/04/05/generic-business-faces-tougher-slog/
Recent articles
- Camber Pharmaceuticals Launches Generic Namenda®
- 28 New Generics in 2022 and Anticipates Record Number of Approvals in 2023
- Camber Pharmaceuticals Launches Generic Cambia®
- Camber Pharmaceuticals Launches Generic Kuvan® Tablets and Powder for Oral Solution
- Camber Pharmaceuticals Launches Generic Vimpat® Injection
- Camber Pharmaceuticals Launches Generic Naprosyn®